WIL Research Laboratories Acquires Midwest BioResearch

Drug Discovery News
(March 5, 2009)

ASHLAND, Ohio-Contract research organization (CRO) WIL Research Laboratories LLC and its parent company WIL Research Holding Co. announced last month the acquisition of Midwest BioResearch, a company that provides drug disposition and toxicology services to drug developers. Neither company provided financial details of the deal. WIL Research, which says it specializes in toxicology services, said it hopes to benefit from Midwest BioResearch's expertise in immunoanalytical and bioassay techniques and small molecule bioanalysis.

"Midwest BioResearch rounds out our service offerings, particularly in the areas of genetic toxicity and biotech and clinical support capabilities," said WIL Research Vice President and CSO Dr. Christopher Chengelis in a company statement.

Download Full Article >